News | January 23, 2026
Dr Reddys Laboratories consolidated Q3 FY26 PAT drops to Rs. 1209.8 Cr, expands global pipeline
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
The AI Nurse Companion, designed as a language-first learning platform, allows students to gain real-world German language proficiency through immersive practice
The agreement to sell B Medical Systems marks a major step forward in simplifying the portfolio to prioritize our core capabilities with the highest strategic impact
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
The multicenter study will enroll 75 patients across 16 sites in Germany, Bulgaria, Poland, and Spain
The expansion includes a larger technical and service team and increased local procurement
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Convenient subcutaneous option has potential to reach more patients with same clinical benefits as Saphnelo IV infusion
The ChemiSphere app exemplifies how M-Trust technology transforms workflows into seamless digital experiences
Subscribe To Our Newsletter & Stay Updated
